|
KIAA0284 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.93490000372543E-08 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.458390E-01 |
| Stage1-vs-Stage3 |
4.661800E-01 |
| Stage1-vs-Stage4 |
4.708300E-02 |
| Stage2-vs-Stage3 |
6.899500E-02 |
| Stage2-vs-Stage4 |
6.380400E-03 |
| Stage3-vs-Stage4 |
1.702820E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.54610002578437E-09 |
| Normal-vs-Asian |
4.44089209850063E-16 |
| Caucasian-vs-AfricanAmerican |
2.027800E-01 |
| Caucasian-vs-Asian |
1.468980E-01 |
| AfricanAmerican-vs-Asian |
8.612200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
8.874200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
7.409400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.493000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.753400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.427600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.640960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.755400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.446600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.424600E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
4.902800E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.62409996562474E-09 |
| Tall-VS-Other |
4.044000E-01 |
| Tall-VS-Normal |
2.4757973449141E-14 |
| Follicular-VS-Other |
1.430000E-02 |
| Follicular-VS-Normal |
2.32729999999348E-05 |
| Other-VS-Normal |
1.275530E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.99840144432528E-15 |
| N0-vs-N1 |
4.936200E-02 |
|
|
